Molecular Templates Inc (MTEM)

NASDAQ
0.889
-0.023(-2.56%)
After Hours
0.851
-0.038(-4.274%)
- Real-time Data
  • Volume:
    91,688
  • Day's Range:
    0.870 - 0.961
  • 52 wk Range:
    0.752 - 8.290

MTEM Overview

Prev. Close
0.912
Day's Range
0.87-0.961
Revenue
33.25M
Open
0.913
52 wk Range
0.752-8.29
EPS
-1.38
Volume
91,688
Market Cap
50.1M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
290,614
P/E Ratio
-
Beta
-
1-Year Change
-87.17%
Shares Outstanding
56,351,647
Next Earnings Date
Nov 15, 2022
What is your sentiment on Molecular Templates?
or
Market is currently closed. Voting is open during market hours.

Molecular Templates Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Molecular Templates Inc Analysis

Molecular Templates Inc Company Profile

Molecular Templates Inc Company Profile

Employees
261

Molecular Templates, Inc. is a clinical stage biopharmaceutical company that is focused on the discovery and development of differentiated, targeted, biologic therapeutics for cancer and other serious diseases. The Company utilizes its biologic drug platform to design and generate engineered toxin bodies (ETBs). ETBs use a genetically engineered version of the Shiga-like Toxin A subunit (SLTA), a ribosome inactivating bacterial protein. The Company is developing ETBs for various targets, including CD20, CD38, HER2, and PD-L1. CD20 is central to B cell malignancies and is clinically validated as a target for the treatment of lymphomas and autoimmune disease. CD38 has been validated as a clinical target in the treatment of multiple myeloma. HER2 is clinically validated as a target for the treatment of solid tumors including breast and gastric cancer. PD-L1 is central to immune checkpoint pathways and is a target expressed in a variety of solid tumor cancers.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong BuyStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • Gonna be in the green today!!🚀🚀🚀
    0
    • It a buy
      0
      • 24$ next stop
        0
        • Positive phase 1 results for new drug could help move this stock considerably. From what I've read, results are expected in January.
          0
          • It will reach 1$ in coming days
            0
            • Do you know about any good news?
              1